Paul Lammers
President, Repros Therapeutics.
Companies
- Decoy Therapeutics Inc.Board member Jul 23, 2019 to now1
- SYNLOGIC, INC.Board member Sep 30, 2015 to Mar 14, 20162
- SYNLOGIC, INC.Chief executive officer Sep 30, 2015 to Mar 14, 20162
- SYNLOGIC, INC.President Sep 30, 2015 to Mar 14, 20162
- Repros TherapeuticsPresident Feb 27, 2009 to Feb 27, 20093
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Decoy Therapeutics Inc. DCOY2,001 shares4$2.3K at $1.17Aug 31, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 31, 2026Granted 2,000 shares of Decoy Therapeutics Inc.4
- Jan 3, 2023Granted 1,440 shares of Decoy Therapeutics Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSYNLOGIC, INC., Board member
- 3SEC EDGARRepros Therapeutics, President
- 4
- 5SEC EDGARForm 4 filed Jan 5, 2023